Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
A6NF34
UPID:
ANTRL_HUMAN
Alternative names:
-
Alternative UPACC:
A6NF34; H3BPS2
Background:
The Anthrax toxin receptor-like protein, identified by its unique accession number A6NF34, plays a crucial role in cellular processes. Its structure and function, while not fully delineated, are pivotal in understanding cellular mechanisms.
Therapeutic significance:
Understanding the role of Anthrax toxin receptor-like could open doors to potential therapeutic strategies. Its involvement in key cellular processes makes it a target for innovative drug discovery efforts.